CVE-2026-41085

8.8

Thermo Fisher Scientific · Torrent Suite Dx

Thermo Fisher Scientific Torrent Suite Dx through version 5 is subject to a security vulnerability that may allow authenticated remote attackers to impact system integrity and availability.

Executive summary

Thermo Fisher Scientific Torrent Suite Dx software through version 5 contains a high-severity vulnerability that could permit unauthorized actions by an authenticated attacker.

Vulnerability

The exact nature of the vulnerability is not publicly detailed, but the CVSS vector (AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H) indicates an authenticated attacker (PR:L) can achieve high impacts on confidentiality, integrity, and availability via network access.

Business impact

With a CVSS score of 8.8 (High), this vulnerability represents a significant risk to the operational integrity of laboratory systems. Unauthorized access or manipulation of clinical data could lead to compromised research outcomes, clinical errors, or total system downtime, necessitating urgent review of security configurations.

Remediation

Immediate Action: Contact Thermo Fisher Scientific support or consult official product documentation to determine if a patch or configuration workaround is available for your specific deployment.

Proactive Monitoring: Monitor authenticated user activity and session logs for any anomalous behavior, particularly administrative actions not associated with standard workflows.

Compensating Controls: Implement strict network segmentation to limit access to the Torrent Suite Dx interface and enforce multi-factor authentication (MFA) for all users to restrict the potential for credential abuse.

Exploitation status

Public Exploit Available: Unknown.

Analyst recommendation

Due to the lack of specific versioning and patch information, organizations must immediately engage with the vendor. Until a patch is applied, ensure that access to the software is strictly limited to authorized personnel and protected by robust authentication mechanisms.

More Thermo Fisher Scientific CVEs